Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA

Blood (2024) 143 (6): 522–534.

https://doi.org/10.1182/blood.2023022020

Published: 2024

Includes: Supplemental data

Journal Articles

Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)

Blood (2022) 140 (Supplement 2): LBA-3.

https://doi.org/10.1182/blood-2022-171733

Published: 2022

Journal Articles

High-Dose Chemotherapy and Autologous Stem Cell Transplant in Elderly and Fit Primary CNS Lymphoma Patients - a Multicenter Study By the Cooperative PCNSL Study Group (MARTA study)

Blood (2022) 140 (Supplement 1): 1773–1774.

https://doi.org/10.1182/blood-2022-162157

Published: 2022

Journal Articles

CXCR4-Targeted Positron Emission Tomography Imaging of Central Nervous System B-Cell Lymphoma

Peter Herhaus, MD, Jana Lipkova, Felicitas Lammer, MD, Julia Slotta-Huspenina, MD, Benedikt Wiestler, MD, Tibor Vag, MD, Stefan Habringer, MD, Igor Yakushev, MD, Constantin Lapa, MD, Tobias Pukrop, MD, Dirk Hellwig, MD, Andreas Buck, MD, Martina Deckert, MD, Hans-Jürgen Wester, PhD, Florian Bassermann, MD PhD, Wolfgang Weber, MD, Markus Schwaiger, MD, Björn Menze, PhD, Ulrich Keller, MD

Blood (2019) 134 (Supplement_1): 2900.

https://doi.org/10.1182/blood-2019-126024

Published: 2019

Journal Articles

Effects on Survival and Neurocognitive Functions of Whole-Brain Radiotherapy (WBRT) and Autologous Stem Cell Transplantation (ASCT) as Consolidation Options after High-Dose Methotrexate-Based Chemoimmunotherapy in Patients with Newly Diagnosed Primary CNS Lymphoma (PCNSL): Results of the Second Randomization of the IELSG32 Trial

Andrés J.M. Ferreri, MD, Kate Cwynarski, MBBS, FRPATH, PhD, Elisa Jacobsen Pulczynski, MD, Christopher P. Fox, MBChB, PhD, Elisabeth Schorb, MD, Paul La Rosée, MD, Mascha Binder, MD, Alberto Fabbri, MD, Valter Torri, MD, Eleonora Minacapelli, MD, Monica Falautano, MD, Fiorella Ilariucci, MD, Achille Ambrosetti, MD, Alexander Röth, MD, Claire Jane Hemmaway, MD, Peter M Johnson, MA, MD, Kim Linton, MBChB, MRCP, PhD, Tobias Pukrop, MD, Jette Sonderskov Gorlov, MD, Monica Balzarotti, MD, Georg Hess, MD, Ulrich Keller, MD, Stephan Stilgenbauer, MD, Jens P. Panse, MD, Alessandra Tucci, MD, Lorella Orsucci, MD, Francesco Pisani, MD, Alessandro Levis, MD, Stefan W. Krause, MD, Hans-Joachim Schmoll, MD PhD, Bernd Hertenstein, MD, Mathias Rummel, MD PhD, Jeffery Smith, MD, Michael Pfreundschuh, MD, PhD, Giuseppina Cabras, MD, Francesco Angrilli, MD, Maurilio Ponzoni, MD, Martina Deckert, MD, Letterio S. Politi, MD, Jurgen Finke, MD, Michele Reni, MD, Franco Cavalli, Emanuele Zucca, Gerald Illerhaus, MD

Blood (2016) 128 (22): 511.

https://doi.org/10.1182/blood.V128.22.511.511

Published: 2016

Journal Articles

Sequential High Dose Immuno-Chemotherapy Followed by Autologous Peripheral Blood Stem Cell Transplantation for Patients with Untreated Primary Central Nervous System Lymphoma - a Multicentre Study by the Collaborative PCNSL Study Group Freiburg

Blood (2012) 120 (21): 302.

https://doi.org/10.1182/blood.V120.21.302.302

Published: 2012

Journal Articles

Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system

Alexander Baraniskin, Jan Kuhnhenn, Uwe Schlegel, Andrew Chan, Martina Deckert, Ralf Gold, Abdelouahid Maghnouj, Hannah Zöllner, Anke Reinacher-Schick, Wolff Schmiegel, Stephan A. Hahn, Roland Schroers

Blood (2011) 117 (11): 3140–3146.

https://doi.org/10.1182/blood-2010-09-308684

Published: 2011

Includes: Supplemental data

Journal Articles

Primary lymphoma of the central nervous system: just DLBCL or not?

Manuel Montesinos-Rongen, Reiner Siebert, Martina Deckert

Blood (2009) 113 (1): 7–10.

https://doi.org/10.1182/blood-2008-04-149005

Published: 2009

Includes: Supplemental data

Journal Articles

Long-Term Disease Control in Patients with Primary Central Nervous System Lymphoma

Blood (2008) 112 (11): 3600.

https://doi.org/10.1182/blood.V112.11.3600.3600

Published: 2008

Journal Articles

Relapse of Central Nervous System Lymphoma after systemic Lymphoma (SCNSL): Clinical Features and Outcome as compared to Primary CNS Lymphoma (PCNSL) Patients

Blood (2008) 112 (11): 3602.

https://doi.org/10.1182/blood.V112.11.3602.3602

Published: 2008

Journal Articles

Early Relapses in Primary CNS Lymphoma (PCNSL) without Intraventricular Treatment.

Ingo G.H. Schmidt-Wolf, MD, Hendrick Pels, MD, Annika Jurgens, MD, Axel Glasmacher, MD, Holger Schulz, MD, Andreas Engert, MD, Michael Linnebank, MD, Gabriele Schackert, MD, Heinz Reichmann, MD, Frank Kroschinsky, MD, Marlies Vogt-Schaden, MD, Gertlinde Egerer, MD, Carlo Schaller, MD, Monika Lamprecht, MD, Ulrich Bogdahn, MD, Martina Deckert, MD, Rolf Fimmers, MD, Christoph Bangard, MD, Uwe Schlegel, MD

Blood (2007) 110 (11): 4440.

https://doi.org/10.1182/blood.V110.11.4440.4440

Published: 2007

Journal Articles

Polychemotherapy in patients with primary CNS lymphoma.

Axel Glasmacher, MD, Hendrik Pels, MD, Christoph Helmstaedter, MD, Martina Deckert, MD, Frank Kroschinsky, MD, Gabriele Schackert, MD, Heinz Reichmann, MD, Gerlinde Egerer, MD, Anthony Ho, MD, Holger Schulz, MD, Andreas Engert, MD, Volker Diehl, MD, Udo Bode, MD, Thomas Klockgether, MD, Uwe Schlegel, MD, Ingo G.H. Schmidt-Wolf, MD

Blood (2004) 104 (11): 3304.

https://doi.org/10.1182/blood.V104.11.3304.3304

Published: 2004

Journal Articles

Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation

Manuel Montesinos-Rongen, Dirk Van Roost, Carlo Schaller, Otmar D. Wiestler, Martina Deckert

Blood (2004) 103 (5): 1869–1875.

https://doi.org/10.1182/blood-2003-05-1465

Published: 2004

NARROW

Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA

Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)

High-Dose Chemotherapy and Autologous Stem Cell Transplant in Elderly and Fit Primary CNS Lymphoma Patients - a Multicenter Study By the Cooperative PCNSL Study Group (MARTA study)

CXCR4-Targeted Positron Emission Tomography Imaging of Central Nervous System B-Cell Lymphoma

Sequential High Dose Immuno-Chemotherapy Followed by Autologous Peripheral Blood Stem Cell Transplantation for Patients with Untreated Primary Central Nervous System Lymphoma - a Multicentre Study by the Collaborative PCNSL Study Group Freiburg

Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system

Primary lymphoma of the central nervous system: just DLBCL or not?

Long-Term Disease Control in Patients with Primary Central Nervous System Lymphoma

Relapse of Central Nervous System Lymphoma after systemic Lymphoma (SCNSL): Clinical Features and Outcome as compared to Primary CNS Lymphoma (PCNSL) Patients

Early Relapses in Primary CNS Lymphoma (PCNSL) without Intraventricular Treatment.

Polychemotherapy in patients with primary CNS lymphoma.

Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only